top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Cancer Plasticity and the Microenvironment: Implications for Immunity and Therapy Response
Cancer Plasticity and the Microenvironment: Implications for Immunity and Therapy Response
Autore Ferrao Petranel T
Pubbl/distr/stampa Frontiers Media SA, 2019
Descrizione fisica 1 online resource (186 p.)
Soggetto topico Medicine and Nursing
Oncology
Soggetto non controllato cancer plasticity
Epithelial-to-mesenchymal transition (EMT)
heterogeneity
immune checkpoint inhibitors
Immune Evasion
Immunotherapy
therapy resistance
Tumor microenvironment (TME)
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Cancer Plasticity and the Microenvironment
Record Nr. UNINA-9910557266803321
Ferrao Petranel T  
Frontiers Media SA, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Free Radical Research in Cancer
Free Radical Research in Cancer
Autore Čipak Gašparović Ana
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (192 p.)
Soggetto topico Technology: general issues
Soggetto non controllato 4-hydroxy-2-nonenal
5-Fluorouracil
androgen deprivation therapy
androgen receptor (AR), AR-V7
anti-androgen
antioxidant
antioxidant proteins
antioxidant therapy
antioxidants
ascorbate
ayurveda
bardoxolone methyl
bleomycin
breast cancer
breast cancer stem cells
calcium channel
cancer
cancer chemotherapy
cancer metabolism
cancer treatment
carbonylation
castration-resistant prostate cancer
cell death
chemoprevention and chemotherapy
chemoresistance
chemotherapy-induced toxicity
cisplatin
combination therapy
deferasirox
doxorubicin
enzalutamide
extracellular matrix
free radicals
granulosa cell tumor
lapachone
light
lung cancer
menadione
methotrexate
mitochondria
myelodysplastic syndromes
n/a
new therapeutic strategies
nitric oxide
NQO1
NQO1*2
NRF2
ovary
oxaliplatin
oxidative stress
ozone therapy
photodynamic therapy
polymorphism
prostate cancer
quinone
reactive oxygen species
reactive oxygen species (ROS)
singlet oxygen
sperm
therapy resistance
triphala
Trolox
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557152603321
Čipak Gašparović Ana  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
New Aspects of Cancer Stem Cell Biology : Implications for Innovative Therapies
New Aspects of Cancer Stem Cell Biology : Implications for Innovative Therapies
Autore Cavallaro Ugo
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (208 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato ALDH1
ATAC-seq
B4GALT1
bevacizumab
bowel cancer
breast cancer
Cadherin 11
cancer stem cell
cancer stem cells
cancer therapy
cell adhesion molecule
chemo-resistance
chemoresistance
chemotherapy resistance
colon
colorectal
CSCs
dasatinib
early breast cancer
EC-8042
epithelial-mesenchymal transition
exosomes
genetic heterogeneity
genome-wide
HDAC inhibitors
head and neck squamous cell carcinoma
immunohistochemistry
L1CAM
lipid
LUAD
lung cancer
metabolism
neoadjuvant chemotherapy
NSCLC
oral cancer risk
oral epithelial dysplasia
oral squamous cell carcinoma
organoid
ovarian cancer
Ovarian cancer
RNA-seq
saracatinib
SNP array
solid cancer
SOX2
SRC
stem cell
therapeutic resistance
therapy resistance
TNBC
transcriptome
tumor progression
tumoroid
Wnt signaling
WNT signaling
β-catenin
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti New Aspects of Cancer Stem Cell Biology
Record Nr. UNINA-9910557112003321
Cavallaro Ugo  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Oncogenic RAS-dependent Reprogramming of Cellular Plasticity
Oncogenic RAS-dependent Reprogramming of Cellular Plasticity
Autore Rimessi Alessandro
Pubbl/distr/stampa Frontiers Media SA, 2020
Descrizione fisica 1 online resource (127 p.)
Soggetto topico Medicine and Nursing
Oncology
Soggetto non controllato cancer hallmarks
cellular plasticity
oncogenesis
oncogenic Ras
therapy resistance
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557414403321
Rimessi Alessandro  
Frontiers Media SA, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Pheochromocytoma (PHEO) and Paraganglioma (PGL)
Pheochromocytoma (PHEO) and Paraganglioma (PGL)
Autore Pacak Karel
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 online resource (380 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato 11C-hydroxy-ephedrine
177Lu-DOTATATE
18F-FDOPA
adaptive immunity
adrenal incidentaloma
adrenal tumor
adrenocortical carcinoma
adrenomedullary function
angiogenesis
arrhythmia
average real variability
blood pressure variability
calorimetry
carotid body
catecholamine
catecholamines
chromogranin A
chromosomal alteration
CNV detection
comparative genomics
cryoablation
diabetes mellitus
dog
ectopic secretion
energy metabolism
EPAS1
erythropoietin
FGF21
fluorescence imaging
GAPP
germline mutation
global longitudinal strain
GTV
head and neck
hereditary
HIF
histology
hypertension
hypotension
hypoxia
hypoxia-inducible factor
immunohistochemistry
immunotherapy
inflammation
innate immunity
lL-6
meta-analysis
metanephrines
metastatic
metastatic OR malignant pheochromocytoma
minimally invasive procedure
mitochondria
mortality
mouse pheochromocytoma cells
mutation
n/a
NET
neural crest
neuroendocrine
neuroendocrine tumor
neurogenesis
neutrophil
next-generation sequencing
NF1
normetanephrines
obesity
pan-cancer analysis
paraganglioma
PASS
pathogen-associated molecular patterns
PCC
peptide receptor radiotherapy
percutaneous ablation
percutaneous ethanol injection
PET
PET-CT
PGL
pheochromocytoma
pheochromocytoma and paraganglioma
phosphorylation tyrosine hydroxylase
polycythemia
postoperative
PPGL
PRRT
pseudohypoxia
radiofrequency ablation
radiosensitization
radiotherapy
SDHB
SDHD
somatostatinoma
speckle-tracking echocardiography
spheroids
sporadic
stem-like tumor cells
subclinical systolic dysfunction
succinate dehydrogenase
T cell
targeted therapy
TCA cycle
therapy resistance
toll-like receptor
transgenic mice
vasculogenesis
VHL
weighted standard deviation
xenograft
ISBN 3-03921-655-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Pheochromocytoma
Record Nr. UNINA-9910367743903321
Pacak Karel  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Targeting STAT3 and STAT5 in Cancer
Targeting STAT3 and STAT5 in Cancer
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (578 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato ADAM17
adoptive T cell therapy
AKT
androgens
apoptosis
autoimmune disease
autosomal-dominant hyper IgE syndrome
Bone Marrow Failure Syndromes
breast cancer
cancer
cancer models
cancer progression
cancer-stem cell
CD38
CD4+ T cells
CD8+ T cells
cell cycle
cell hierarchy
chaperones
chemotherapy resistance
cirrhosis
colon cancer
companion animals
comparative oncology
cytokine
cytokine receptor signaling
dynamic programming
endoplasmic reticulum (ER) stress
epidermal growth factor receptor (EGF-R)
ERK1/2
escape mechanisms
gain-of-function mutation
glioblastoma
glioma
growth hormone insensitivity syndrome
heat shock proteins
hedging
hematopoietic cancers
hepatitis C virus (HCV)
hepatocellular carcinoma (HCC)
hepatocyte nuclear factor 4 alpha (HNF4A)
immune check point
immune suppression
immunosuppression
immunotherapy
inflammation
inflammation associated cancer
inflammatory hepatocellular adenomas
interleukin-6
JAK
JAK family of protein tyrosine kinases
JAK2 V617F
knockout
lipopolyplex
lung cancer
lymphocytes
lymphoma
M2 macrophages
melanoma
meta-analysis
metalloprotease
metastasis
microRNA-122 (miR-122)
mitochondria
MPN
mTOR
multiple myeloma
mutations
myeloid cells
myeloid leukemia
n/a
nanoparticle
neoplastic stem cells
NGS
NK cells
nuclear factor erythroid 2-related factor 2 (NRF2)
nuclear pore complex
nuclear transport receptors
nucleocytoplasmic shuttling
ovarian cancer
oxidative stress (OS)
PD-L1
PEI
pharmacological inhibitor
pharmacological inhibitors
polyethylenimine
post-decision state variable
prolactin
proliferation
prostate cancer
RHOA
risk management
S3I-1757
SH2 domain
shedding
signal transducer and activator of transcription
signal transducer and activator of transcription 3 (STAT3)
siRNA delivery
siRNA/RNAi
small-molecule inhibitors
solid cancers
stabilization
STAT
STAT transcription factors
STAT3
STAT3 inhibitor XIII
STAT5
STAT5 signaling
STAT5B signaling
stem/progenitor cells
stemness
T-cell large granular lymphocytic leukemia
T-cell leukemia
T-cell prolymphocytic leukemia
T-cells
T-PLL
targeted therapy
targeting
therapeutic targeting
therapy resistance
trans-signaling
transaction costs
tumor microenvironment
tumor necrosis factor alpha (TNFα)
tumor suppression
tumor-associated macrophages
tumor-immune cell interactions
tumorigenesis
tyrosine kinase 2
unfolded protein response (UPR)
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557623503321
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Tumor Microenvironment and Resistance to Current Therapies
Tumor Microenvironment and Resistance to Current Therapies
Autore Lasfar Ahmed
Pubbl/distr/stampa Frontiers Media SA, 2020
Descrizione fisica 1 online resource (148 p.)
Soggetto topico Pharmacology
Science: general issues
Soggetto non controllato cancer cell signaling
cancer resistance
immunotherapy
targeted therapy
therapy resistance
tumor microenvironment
tumor-targeting
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557262603321
Lasfar Ahmed  
Frontiers Media SA, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui